(Q34625011)

English

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

type 2 diabetes

0 references

0 references

0 references

Giuseppe Remuzzi

object named as

Giuseppe Remuzzi

9

0 references

author name string

Dick de Zeeuw

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Rajiv Agarwal

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Michael Amdahl

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Paul Audhya

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Daniel Coyne

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Tushar Garimella

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Hans-Henrik Parving

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Yili Pritchett

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Eberhard Ritz

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dennis Andress

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

1 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

376

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

9752

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1543-1551

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Retarding progression of chronic renal disease: the neglected issue of residual proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy: Post Hoc Analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Telmisartan, ramipril, or both in patients at high risk for vascular events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Avosentan for overt diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Renoprotective role of the vitamin D receptor in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiproteinuric effect of oral paricalcitol in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The selective vitamin D receptor activator for albuminuria lowering (VITAL) study: study design and baseline characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of renin-angiotensin gene expression in the kidney by paricalcitol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Aliskiren combined with losartan in type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Ultraviolet light may contribute to geographic and racial blood pressure differences

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of vitamin D in blood pressure homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961032-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(10)61032-X

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

release_shcbgy4dezckjpfc5h47seemay

1 reference

https://api.fatcat.wiki/v0/release/shcbgy4dezckjpfc5h47seemay

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34625011&oldid=1844509016"